T
o maintain health and function in response to inhaled environmental irritants and toxins, the lungs and airways depend upon an innate defense system that involves the secretion of mucus (i.e., mucin, salts, and water) by airway epithelium onto the apical surface to trap foreign particles. Airway mucus is then transported in an oral direction via ciliary beating and coughing, which helps to keep the airways clear. CFTR (cystic fibrosis transmembrane conductance regulator) is a cAMP-regulated Cl -channel in the apical membrane of epithelium that contributes to salt and water secretion onto the luminal surface of airways, thereby ensuring that secreted mucus is sufficiently hydrated for movement along the epithelial surface. Dehydration of airway mucus, as occurs in cystic fibrosis, results in a more viscous, less mobile secretion that compromises the lung's innate defense system by facilitating a build-up of foreign particles and bacterial growth. Related to this situation is chronic obstructive pulmonary disease (COPD), which is a leading cause of death globally. A major cause of COPD is cigarette smoking, which has been reported to decrease the cellular levels of CFTR in airway epithelia. indicators targeted to select sub-cellular organelles (i.e., mitochondria, lysosomes). Exposure of cultured cells to the vapor phase of cigarette smoke was used to mimic that experienced by a typical smoker (i.e., 1 puff per min for 10 min (acute exposure) or 10 puffs per 2 h for 8 h (chronic exposure)).
Using a variety of pharmacologic inhibitors to block major signal transduction pathways, the authors discovered that cigarette smoke-induced decrease in cellular CFTR was insensitive to agents that interfered with protein phosphorylation (i.e., the cAMP/PKA inhibitor H89, the broad spectrum kinase inhibitor staurosporine, the phosphatase 1/2A inhibitor okadaic acid and the PI-3 kinase inhibitors LY294002 and wortmannin 2+ may be involved in longterm events (e.g., gene transcription) that could promote epithelial cell survival in response to the toxic insults associated with smoking. Although the connection between cigarette smoking and COPD is well-established from a health care perspective, the results of this study increase our knowledge of the underlying molecular pathology evoked by chronic cigarette smoke exposure and point to additional targets/strategies that may mitigate the airway dysfunction associated with this disease.
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